 | Up a level |
Augustin, M. and Hallek, M. (2020). Current study results underline cautious commenting. Internist, 61 (6). S. 646 - 647. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2022). Antibody Therapy in Patients with COVID-19. Internist, 63 (5). S. 573 - 577. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Antibody therapy in patients with COVID-19. Internist, 62 (5). S. 572 - 577. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. . Development of Vaccines for Prevention of COVID-19. Internist. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Development of Vaccines for the Prevention of COVID-19-Part 2. Internist, 62 (3). S. 337 - 341. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. . Development of vaccines for prevention of COVID-19: part 2. Internist. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Development of vaccines for prevention of COVID-19: part 3. Internist, 62 (6). S. 690 - 694. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2020). Morphological and molecular Changes in the Lungs of COVID-19 Patients. Internist, 61 (12). S. 1304 - 1308. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2020). Remdesivir for Patients with COVID-19. Internist, 61 (8). S. 869 - 873. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2020). Remdesivir for patients with severe COVID-19. Internist, 61 (6). S. 644 - 646. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2022). Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19. Internist, 63 (4). S. 461 - 465. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Augustin, M., Hallek, M. and Nitschmann, S. (2021). Vaccine Development for Prevention of COVID-19 in Adolescents. Internist, 62 (12). S. 1360 - 1364. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289
Gutknecht, M., Danner, M. and Augustin, M. (2016). USING ANALYTIC HIERARCHY PROCESS TO WEIGHT PATIENT-RELEVANT OUTCOMES IN THE TREATMENT OF PSORIASIS FOR CALCULATING THE PATIENT BENEFIT INDEX. Value Health, 19 (7). S. A389 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733
Gutknecht, M., Schaarschmidt, M. L., Danner, M. and Augustin, M. (2017). Which Therapeutic Goals do Patients prefer with Psoriasis? Results of a Method Comparison. J. Dtsch. Dermatol. Ges., 15. S. 126 - 128. HOBOKEN: WILEY. ISSN 1610-0387
Horn, C., Augustin, M., Ercanoglu, M. S., Heger, E., Knops, E., Bondet, V, Duffy, D., Chon, S-H, Nierhoff, D., Oette, M., Schaefer, H., Vivaldi, C., Held, K., Anderson, J., Geldmacher, C., Suarez, I, Rybniker, J., Klein, F., Faetkenheuer, G., Muller-Trutwin, M. and Lehmann, C. (2021). HIV DNA reservoir and elevated PD-1 expression of CD4 T-cell subsets particularly persist in the terminal ileum of HIV-positive patients despite cART. HIV Med., 22 (5). S. 397 - 409. HOBOKEN: WILEY. ISSN 1468-1293
Zietze, H. A., Augustin, M., Kienitz, C., Theobald, K., Ihle, P. and Cabral, C. (2018). EPIDEMIOLOGY AND TREATMENT PATTERNS IN ADULT PATIENTS WITH ATOPIC DERMATITIS: ANALYSIS OF LONGITUDINAL DATA FROM THE GERMAN STATUTORY HEALTH INSURANCE SYSTEM. Value Health, 21. S. S431 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733